Top Stories

www.espn.com - TOP

Latest TOP news from www.espn.com

Follow live: No. 1 overall seed Duke
null[read more]

TCU backs up its tough talk, bounces Buckeyes
Xavier Edmonds converted a layup to beat the shot clock with 4.3 seconds left, and No. 9 seed TCU held off a furious second-half rally by eighth-seeded Ohio State for a 66-64 victory to open the first round of the NCAA tournament.[read more]

🏀 Best bets for men's tournament first round
As you prepare for tipoff, here are our best bets for the first round, plus picks for the new Eliminator game.[read more]

Blue Jays righty Yesavage to begin season on IL
Manager John Schneider said Thursday that Trey Yesavage will begin the season on the injured list due to a shoulder impingement.[read more]

LeBron, Doncic, Reaves questionable for Lakers
Lakers stars LeBron James, Luka Doncic and Austin Reaves are questionable for Thursday night's matchup against the Miami Heat.[read more]

Sources: Heat to waive Rozier before playoffs
The Miami Heat are expected to waive guard Terry Rozier before the end of the regular season to create a roster spot for the team's playoff run, sources confirmed to ESPN.[read more]

Iran soccer chief: We'll boycott U.S., not WCup
Iran will "boycott the United States, but not the World Cup," the president of the country's football federation said Wednesday, in quotes reported by Iran's Fars news agency.[read more]

Pistons star Cunningham out with collapsed lung
Pistons star Cade Cunningham has been diagnosed with a collapsed lung and is expected to miss an extended period of time.[read more]

UK's Pope offers little on Lendeborg's money talk
Kentucky men's basketball coach Mark Pope had a lot of things to say about Yaxel Lendeborg's comments that he received a multimillion dollar offer to play for the Wildcats -- except for saying the Michigan star was wrong.[read more]

Profar gets full PED ban after appeal resolved
Braves outfielder Jurickson Profar will miss the entire 2026 season after his appeal of a positive test for performance-enhancing drugs was resolved.[read more]